Our research group focuses on understanding the role of G-protein-coupled receptors (GPCRs, targets for about ~50% of current drugs) together with their transmitters in humans. We use in vitro pharmacology, to determine how these are altered with disease. Major interests include the role of apelin, Elabela and endothelin-1 in human pathophysiology. Previous research has focussed on other peptides including urotensin II, ghrelin, neuromedin U, kisspeptins, trace amines.Wider research interests are reflected through co-executive member of the International Union of Basic and Clinical Pharmacology Committee on Receptor Nomenclature and Drug Classification. This committee has oversight of medicines and tool compounds databases: GuidetoPharmacology https://www.guidetopharmacology.org/ GuidetoImmunoPharmacology https://www.guidetoimmunopharmacology.org/immuno/index.jsp GuidetoPharmacologyOfMalaria https://www.guidetopharmacology.org/malaria/gtmpHelpPage.jsp